Search

Your search keyword '"Carboplatin -- Intellectual property"' showing total 345 results
Start Over Descriptor "Carboplatin -- Intellectual property"
345 results on '"Carboplatin -- Intellectual property"'

201. 'Extracellular Matrix Compositions For The Treatment Of Cancer' in Patent Application Approval Process (USPTO 20200360430)

Subjects
Cancer treatment, Cancer, Vincristine -- Intellectual property, Carboplatin -- Intellectual property, Biotechnology industry, Pharmaceuticals and cosmetics industries
Abstract

2020 DEC 9 (NewsRx) -- By a News Reporter-Staff News Editor at Biotech Week -- A patent application by the inventors Naughton, Gail K. (Encinitas, CA); Pinney, Emmett (Poway, CA), [...]

Published
2020

202. Patent Issued for Nanoparticles For Brain Targeted Drug Delivery (USPTO 10,842,755)

Subjects
Drug delivery systems -- Intellectual property, Vincristine -- Intellectual property, Carboplatin -- Intellectual property, Sulindac -- Intellectual property, Health, Psychology and mental health
Abstract

2020 DEC 7 (NewsRx) -- By a News Reporter-Staff News Editor at Mental Health Weekly Digest -- A patent by the inventor Xu, Peisheng (Chapin, SC), filed on February 19, [...]

Published
2020

203. 'Surgical Stapling Device' in Patent Application Approval Process (USPTO 20200352565)

Subjects
Vaccines -- Intellectual property, Ramucirumab, Canakinumab, Atezolizumab -- Intellectual property, Bevacizumab -- Intellectual property, Kinase inhibitors -- Intellectual property, Amino acids -- Intellectual property, Carboplatin -- Intellectual property, Antineoplastic agents -- Intellectual property, Health
Abstract

2020 DEC 2 (NewsRx) -- By a News Reporter-Staff News Editor at Vaccine Weekly -- A patent application by the inventor Schulz-Jander, Daniel A. (Oakland, CA), filed on April 3, [...]

Published
2020

205. Patent Application Titled 'Surgical Stapling Device' Published Online (USPTO 20200352570)

Subjects
Ramucirumab, Canakinumab, Atezolizumab -- Intellectual property, Bevacizumab -- Intellectual property, Kinase inhibitors -- Intellectual property, Amino acids -- Intellectual property, Carboplatin -- Intellectual property, Antineoplastic agents -- Intellectual property, Health
Abstract

2020 NOV 30 (NewsRx) -- By a News Reporter-Staff News Editor at Hematology Week -- According to news reporting originating from Washington, D.C., by NewsRx journalists, a patent application by [...]

Published
2020

206. 'Surgical Stapling Device' in Patent Application Approval Process (USPTO 20200352571)

Subjects
Ramucirumab, Canakinumab, Atezolizumab -- Intellectual property, Bevacizumab -- Intellectual property, Kinase inhibitors -- Intellectual property, Amino acids -- Intellectual property, Carboplatin -- Intellectual property, Antineoplastic agents -- Intellectual property, Health
Abstract

2020 NOV 30 (NewsRx) -- By a News Reporter-Staff News Editor at Hematology Week -- A patent application by the inventors Hodgkinson, Gerald N. (Killingworth, CT); Soltz, Michael A. (Fairfield, [...]

Published
2020

207. Patent Issued for Immunodeficient Non-Human Animal (USPTO 10,820,580)

Subjects
B cells, Carboplatin -- Intellectual property, Pemetrexed -- Intellectual property, Business, Health
Abstract

2020 NOV 20 (NewsRx) -- By a News Reporter-Staff News Editor at Medical Patent Business Week -- According to news reporting originating from Alexandria, Virginia, by NewsRx journalists, a patent [...]

Published
2020

208. Patent Application Titled 'Hypertonic Pharmaceutical Compositions Containing An Anti-Platinum Chemoprotectant Agent' Published Online (USPTO 20200338119)

Subjects
Chemotherapy, Povidone -- Intellectual property, Carboplatin -- Intellectual property, Dimercaprol, Business, Health
Abstract

2020 NOV 20 (NewsRx) -- By a News Reporter-Staff News Editor at Medical Patent Business Week -- According to news reporting originating from Washington, D.C., by NewsRx journalists, a patent [...]

Published
2020

209. Patent Application Titled 'Spinel Ferrite Impregnated Mesoporous Silica Containing A Platinum Complex' Published Online (USPTO 20200338122)

Subjects
Spinel group -- Intellectual property, Cancer, Iron compounds -- Intellectual property, Carboplatin -- Intellectual property, Biotechnology industry, Pharmaceuticals and cosmetics industries
Abstract

2020 NOV 18 (NewsRx) -- By a News Reporter-Staff News Editor at Biotech Week -- According to news reporting originating from Washington, D.C., by NewsRx journalists, a patent application by [...]

Published
2020

210. Patent Issued for Treating Cancer With ATR Inhibitors (USPTO 10,813,929)

Subjects
Vertex Pharmaceuticals Inc. -- Intellectual property, Cancer treatment, Cetuximab, Crizotinib, Pancreatic cancer, Carboplatin -- Intellectual property, Pharmaceutical industry -- Intellectual property, Health, Health care industry
Abstract

2020 NOV 15 (NewsRx) -- By a News Reporter-Staff News Editor at Medical Devices & Surgical Technology Week -- A patent by the inventors Pollard, John Robert (Abingdon, GB); Reaper, [...]

Published
2020

213. 'Biodegradable Polymer Based Implants For Ocular Drug Delivery' in Patent Application Approval Process (USPTO 20200330377)

Subjects
Drug delivery systems -- Intellectual property, Ophthalmic agents -- Intellectual property, Carboplatin -- Intellectual property, Fluocinolone, Polymers -- Intellectual property, Health
Abstract

2020 NOV 9 (NewsRx) -- By a News Reporter-Staff News Editor at Hematology Week -- A patent application by the inventors Banerjee, Rupak (Mason, OH); Manna, Soumyarwit (Cincinnati, OH); Augsburger, [...]

Published
2020

214. Patent Application Titled 'Anti-Erbb-2 Antibodies And Uses Thereof' Published Online (USPTO 20200325246)

Subjects
Cancer treatment, Bevacizumab -- Intellectual property, Amino acids -- Intellectual property, Carboplatin -- Intellectual property, Antibodies, Biological products -- Intellectual property, Business, Health
Abstract

2020 NOV 6 (NewsRx) -- By a News Reporter-Staff News Editor at Medical Patent Business Week -- According to news reporting originating from Washington, D.C., by NewsRx journalists, a patent [...]

Published
2020

215. 'Drug Resistant Immunotherapy For Treatment Of A Cancer' in Patent Application Approval Process (USPTO 20200323903)

Subjects
Cancer genetics, Cancer, Vincristine -- Intellectual property, Drug resistance, Carboplatin -- Intellectual property, Immunotherapy, Drug approval, Biotechnology industry, Health, Science and technology
Abstract

2020 NOV 2 (NewsRx) -- By a News Reporter-Staff News Editor at Cancer Gene Therapy Week -- A patent application by the inventors Spencer, Harold Trent (Marietta, GA); Dasgupta, Anindya [...]

Published
2020

216. OncoQuest Receives 'Notice of Allowance' for Patent Protection of the Administration Schedule of Oregovomab and Chemotherapy for Stage III-IV Ovarian Cancer Patients

Subjects
Oregovomab, Cancer prevention, Chemotherapy, Carboplatin -- Intellectual property, Cancer patients, Biological products -- Intellectual property, Ovarian cancer, Patent law, Medical supplies, Cancer treatment, Trademarks, Antibodies, Immunotherapy, General interest, News, opinion and commentary
Abstract

EDMONTON: OncoQuest Inc. has issued the following press release: OncoQuest Inc., a privately held, cancer immunotherapy company today announced that a Notice of Allowance was received from the U.S. Patent [...]

Published
2019

217. OncoQuest Receives 'Notice of Allowance' for Patent Protection of the Administration Schedule of Oregovomab and Chemotherapy for Stage III-IV Ovarian Cancer Patients

Subjects
Carboplatin -- Intellectual property, Patent law, Cancer patients, Biological products -- Intellectual property, Cancer -- Prevention -- Chemotherapy, Immunotherapy, Chemotherapy, Ovarian cancer, Business, News, opinion and commentary
Abstract

EDMONTON, Sept. 25, 2019 /PRNewswire/ - OncoQuest Inc., a privately held, cancer immunotherapy company today announced that a Notice of Allowance was received from the U.S. Patent and Trademark Office [...]

Published
2019

218. Immutep Limited: IMMUTEP ANNOUNCES AUSTRALIAN PATENT GRANTED FOR EFTILAGIMOD ALPHA IN CHEMO-IMMUNOTHERAPY

Subjects
Intellectual property, Chemotherapy, Carboplatin -- Intellectual property, Immunotherapy, Cancer treatment, Cancer, Autoimmune diseases, Biotechnology industries, Novels, Intellectual property, General interest, News, opinion and commentary
Abstract

Sydney, Australia: Immutep Limited has issued the following news release: Immutep Limited (ASX: IMM; NASDAQ: IMMP) ('Immutep' or 'the Company'), a biotechnology company developing novel immunotherapy treatments for cancer and [...]

Published
2019

219. Immutep Limited: IMMUTEP ANNOUNCES EUROPEAN PATENT GRANT FOR EFTILAGIMOD ALPHA IN CHEMO-IMMUNOTHERAPY

Subjects
Intellectual property, Chemotherapy, Carboplatin -- Intellectual property, Immunotherapy, Cancer treatment, Cancer, Antineoplastic agents, Autoimmune diseases, Biotechnology industries, Novels, Intellectual property, General interest, News, opinion and commentary
Abstract

Sydney, Australia: Immutep Limited has issued the following news release: Immutep Limited (ASX: IMM; NASDAQ: IMMP) ('Immutep' or 'the Company'), a biotechnology company developing novel immunotherapy treatments for cancer and [...]

Published
2019

220. Immutep Announces European Patent Grant for Eftilagimod Alpha in Chemo-Immunotherapy

Subjects
Intellectual property, Chemotherapy, Carboplatin -- Intellectual property, Immunotherapy, Cancer treatment, Cancer, Antineoplastic agents, Autoimmune diseases, Biotechnology industries, Novels, Intellectual property, General interest, News, opinion and commentary
Abstract

SYDNEY: Immutep Limited has issued the following news release: Immutep Limited (ASX: IMM; NASDAQ: IMMP) ('Immutep' or 'the Company'), a biotechnology company developing novel immunotherapy treatments for cancer and autoimmune [...]

Published
2019

221. Immutep Announces European Patent Grant for Eftilagimod Alpha in Chemo-Immunotherapy

Subjects
Intellectual property, Chemotherapy, Carboplatin -- Intellectual property, Immunotherapy, Cancer treatment, Cancer, Antineoplastic agents, Autoimmune diseases, Biotechnology industries, Novels, Intellectual property, Banking, finance and accounting industries, Business
Abstract

SYDNEY, Australia, May 23, 2019 (GLOBE NEWSWIRE via COMTEX) -- Immutep Limited (ASX: IMM; NASDAQ: IMMP) ('Immutep' or 'the Company'), a biotechnology company developing novel immunotherapy treatments for cancer and [...]

Published
2019

222. 'Anti-Axl Tyrosine Kinase Receptor Antibodies And Uses Thereof' in Patent Application Approval Process (USPTO 20200317812)

Subjects
Bevacizumab -- Intellectual property, Tyrosine -- Intellectual property, Carboplatin -- Intellectual property, Antibodies, Biological products -- Intellectual property, Phenols (Class of compounds) -- Intellectual property, Business, Health
Abstract

2020 OCT 30 (NewsRx) -- By a News Reporter-Staff News Editor at Medical Patent Business Week -- A patent application by the inventors DING, Mei Yee Vanessa (Singapore, SG); CHOO, [...]

Published
2020

223. Patent Issued for Combination Therapies With anti-CD38 Antibodies (USPTO 10,800,851)

Subjects
B cells, Ocrelizumab -- Intellectual property, Vincristine -- Intellectual property, Carboplatin -- Intellectual property, Obinutuzumab, Biological products -- Intellectual property, Ofatumumab -- Intellectual property, Biotechnology industry, Pharmaceuticals and cosmetics industries
Abstract

2020 OCT 28 (NewsRx) -- By a News Reporter-Staff News Editor at Biotech Week -- Janssen Biotech Inc. (Horsham, Pennsylvania, United States) has been issued patent number 10,800,851, according to [...]

Published
2020

224. Patent Issued for Administration Of NEDD8-Activating Enzyme Inhibitor And Chemotherapeutic Agents (USPTO 10,786,505)

Subjects
Millennium Pharmaceuticals Inc. -- Intellectual property, Chemotherapy, Biotechnology industries -- Intellectual property, Biopharmaceuticals -- Intellectual property, Carboplatin -- Intellectual property, Enzyme inhibitors -- Intellectual property, Health
Abstract

2020 OCT 12 (NewsRx) -- By a News Reporter-Staff News Editor at Clinical Trials Week -- A patent by the inventors Berger, Allison (Arlington, MA); Lightcap, Eric S. (Natick, MA), [...]

Published
2020

225. Researchers Submit Patent Application, 'Human Cancer Cell Metastasis Inhibitory Agent And Human Cancer Cell Determination Agent', for Approval (USPTO 20200289616)

Subjects
Cancer, Cancer prevention, Cancer research, Amino acids -- Intellectual property, Biochemistry, Carboplatin -- Intellectual property, Cancer metastasis, Health
Abstract

2020 OCT 5 (NewsRx) -- By a News Reporter-Staff News Editor at OBGYN & Reproduction Week -- From Washington, D.C., NewsRx journalists report that a patent application by the inventors [...]

Published
2020

226. Researchers Submit Patent Application, 'Cancer Treatments', for Approval (USPTO 20200268884)

Subjects
Cancer treatment, Bevacizumab -- Intellectual property, Cancer research, Skin cancer, Carboplatin -- Intellectual property, Melanoma, Biotechnology industry, Pharmaceuticals and cosmetics industries, Abraxane (Medication) -- Intellectual property, Avastin (Medication) -- Intellectual property
Abstract

2020 SEP 16 (NewsRx) -- By a News Reporter-Staff News Editor at Biotech Week -- From Washington, D.C., NewsRx journalists report that a patent application by the inventors Markovic, Svetomir [...]

Published
2020

228. Patent Application Titled 'Quantifying MGMT Protein For Optimal Cancer Therapy' Published Online (USPTO 20200271654)

Subjects
Expression Pathology Inc. -- Intellectual property, Cancer treatment, Cancer, Biotechnology industries -- Intellectual property, Carboplatin -- Intellectual property, Colorectal cancer, Business, Health, Health care industry
Abstract

2020 SEP 15 (NewsRx) -- By a News Reporter-Staff News Editor at Cancer Weekly -- According to news reporting originating from Washington, D.C., by NewsRx journalists, a patent application by [...]

Published
2020

229. Patent Issued for Pharmaceutical Co-Crystal And Use (USPTO 10,751,318)

Subjects
Carboplatin -- Intellectual property, Pharmaceutical industry -- Intellectual property, Business, Health, Health care industry
Abstract

2020 SEP 8 (NewsRx) -- By a News Reporter-Staff News Editor at Cancer Weekly -- From Alexandria, Virginia, NewsRx journalists report that a patent by the inventor Liu, Xiaozhong (Potomac, [...]

Published
2020

230. Patent Issued for Compounds And Pharmaceutical Composition Associated With Ubiquitination-Proteasome System (USPTO 10,745,350)

Subjects
Cancer treatment, Ubiquitin, Vincristine -- Intellectual property, Pyrimethamine -- Intellectual property, Carboplatin -- Intellectual property, Pemetrexed -- Intellectual property, Business, Health, Health care industry
Abstract

2020 SEP 1 (NewsRx) -- By a News Reporter-Staff News Editor at Cancer Weekly -- From Alexandria, Virginia, NewsRx journalists report that a patent by the inventors Yen, Yun (Arcadia, [...]

Published
2020

231. 'Combination Therapy For Cancer' in Patent Application Approval Process (USPTO 20200254049)

Subjects
Cancer, Vincristine -- Intellectual property, Carboplatin -- Intellectual property, Sorafenib -- Intellectual property, Health, Psychology and mental health
Abstract

2020 AUG 31 (NewsRx) -- By a News Reporter-Staff News Editor at Mental Health Weekly Digest -- A patent application by the inventor Amin, Amr (Al Ain, AE), filed on [...]

Published
2020

232. Researchers Submit Patent Application, 'Anticancer Drug-Containing Plant Virus Particles', for Approval (USPTO 20200246482)

Subjects
Vaccines -- Intellectual property, Drugs -- Intellectual property, Carboplatin -- Intellectual property, Drug approval, Pharmaceutical industry -- Intellectual property, Health
Abstract

2020 AUG 26 (NewsRx) -- By a News Reporter-Staff News Editor at Vaccine Weekly -- From Washington, D.C., NewsRx journalists report that a patent application by the inventors Steinmetz, Nicole [...]

Published
2020

235. Patent Issued for OPRT Expression And Cancer Treatment Outcome (USPTO 10,722,531)

Subjects
Fluorouracil -- Intellectual property, Chemotherapy, Carboplatin -- Intellectual property, Business, Health, Health care industry
Abstract

2020 AUG 11 (NewsRx) -- By a News Reporter-Staff News Editor at Cancer Weekly -- NantOmics LLC (Culver City, California, United States) has been issued patent number 10,722,531, according to [...]

Published
2020

236. Patent Application Titled 'Compounds For Treating Tnbc' Published Online (USPTO 20200230109)

Subjects
Purdue Pharma L.P. -- Intellectual property, Ionizing radiation, Olaparib, Carboplatin -- Intellectual property, Pharmaceutical industry -- Intellectual property, Business, Health, Health care industry
Abstract

2020 AUG 11 (NewsRx) -- By a News Reporter-Staff News Editor at Cancer Weekly -- According to news reporting originating from Washington, D.C., by NewsRx journalists, a patent application by [...]

Published
2020

239. Patent Issued for Agent For Prophylactic And/Or Therapeutic Treatment Of Peripheral Neuropathic Pain Caused By Anticancer Agent (USPTO 10,709,767)

Subjects
Vincristine -- Intellectual property, Chemotherapy, Amino acids -- Intellectual property, Carboplatin -- Intellectual property, Pain management, Business, Health, Health care industry
Abstract

2020 JUL 28 (NewsRx) -- By a News Reporter-Staff News Editor at Cancer Weekly -- A patent by the inventors Kawabata, Atsufumi (Higashiosaka, JP); Suzuki, Hideaki (Tokyo, JP), filed on [...]

Published
2020

240. Patent Application Titled 'Blood-Based Tumor Mutation Burden Predicts Overall Survival In Nsclc' Published Online (USPTO 20200190598)

Subjects
MedImmune L.L.C. -- Intellectual property, Durvalumab -- Intellectual property, Cancer -- Genetic aspects -- Prognosis, Biotechnology industries -- Intellectual property, Carboplatin -- Intellectual property, Pemetrexed -- Intellectual property, Non-small cell lung cancer -- Prognosis -- Genetic aspects, Business, Health, Health care industry
Abstract

2020 JUL 7 (NewsRx) -- By a News Reporter-Staff News Editor at Cancer Weekly -- According to news reporting originating from Washington, D.C., by NewsRx journalists, a patent application by [...]

Published
2020

241. Researchers Submit Patent Application, 'Infusion System', for Approval (USPTO 20200170883)

Subjects
Sulbactam -- Intellectual property, Ticarcillin -- Intellectual property, Micafungin -- Intellectual property, Carboplatin -- Intellectual property, Cephalosporins, Antibacterial agents -- Intellectual property, Antineoplastic agents -- Intellectual property, Decitabine, Business, Health
Abstract

2020 JUN 26 (NewsRx) -- By a News Reporter-Staff News Editor at Medical Patent Business Week -- From Washington, D.C., NewsRx journalists report that a patent application by the inventor [...]

Published
2020

242. Patent Issued for Extracellular Matrix Compositions For The Treatment Of Cancer (USPTO 10,675,303)

Subjects
Cancer treatment, Cancer, Vincristine -- Intellectual property, Carboplatin -- Intellectual property, Biotechnology industry, Pharmaceuticals and cosmetics industries
Abstract

2020 JUN 24 (NewsRx) -- By a News Reporter-Staff News Editor at Biotech Week -- Adaptive Biologix Inc. (San Diego, California, United States) has been issued patent number 10,675,303, according [...]

Published
2020

243. Patent Issued for Cancer Vaccine For Cats (USPTO 10,675,337)

Subjects
Cancer vaccines -- Intellectual property, Transport proteins, Ionizing radiation, Vincristine -- Intellectual property, Amino acids -- Intellectual property, Carboplatin -- Intellectual property, Domestic cats, Biotechnology industry, Pharmaceuticals and cosmetics industries
Abstract

2020 JUN 24 (NewsRx) -- By a News Reporter-Staff News Editor at Biotech Week -- Invectys (Paris, France) has been issued patent number 10,675,337, according to news reporting originating out [...]

Published
2020

245. Researchers Submit Patent Application, 'Combination Of Small Molecule CD-47 Inhibitors With Other Anti-Cancer Agents', for Approval (USPTO 20200147054)

Subjects
Cabazitaxel, Ixazomib, Ceritinib, Zoledronate, Ruxolitinib -- Intellectual property, Ramucirumab, Olaparib, Nivolumab, Carboplatin -- Intellectual property, Obinutuzumab, Nandrolone -- Intellectual property, Rasburicase -- Intellectual property, Pamidronate -- Intellectual property, Cancer, Monoclonal antibodies, Alitretinoin -- Intellectual property, Pembrolizumab, Pegfilgrastim, Belinostat, Decitabine, Durvalumab -- Intellectual property, Palbociclib, Idelalisib, Blinatumomab, Bevacizumab -- Intellectual property, Nilotinib, Plerixafor, Antineoplastic agents -- Intellectual property, Afatinib, Cancer treatment, Temsirolimus, Fulvestrant, Clofarabine, Pertuzumab, Dasatinib, Nelarabine, Ixabepilone, Axitinib, Vincristine, Ibrutinib, Editors, Tositumomab, Abiraterone, Dabrafenib, Pemetrexed, Cetuximab, Pomalidomide, Carfilzomib, Romidepsin, Atezolizumab, Ipilimumab, Technology, Pralatrexate, Enzalutamide, Sunitinib, Niraparib, Regorafenib, Crizotinib, Necitumumab, Baricitinib, Lapatinib, Interferon alfa-2a, Degarelix, Biotechnology, Talazoparib, Dinutuximab, Everolimus, Vorinostat, Ponatinib, Bosutinib, Rucaparib, Panitumumab, Ofatumumab, Sorafenib, Bendamustine, Ibritumomab tiuxetan, Trametinib, Denosumab, Vemurafenib, Pazopanib, Eculizumab, Aflibercept, Panobinostat, Daratumumab, Biotechnology industry, Pharmaceuticals and cosmetics industries
Abstract

2020 JUN 3 (NewsRx) -- By a News Reporter-Staff News Editor at Biotech Week -- From Washington, D.C., NewsRx journalists report that a patent application by the inventors Ramachandra, Muralidhara [...]

Published
2020

246. Patent Issued for Anti-Annexin A2 Monoclonal Antibodies (USPTO 10,654,921)

Subjects
Annexins, Monoclonal antibodies, Bevacizumab -- Intellectual property, Cancer research, Amino acids -- Intellectual property, Carboplatin -- Intellectual property, Biological products -- Intellectual property, Antibodies, Technology, Cancer, Editors, Business, Health, Health care industry
Abstract

2020 JUN 2 (NewsRx) -- By a News Reporter-Staff News Editor at Cancer Weekly -- Agency for Science - Technology and Research (Singapore, Singapore) has been issued patent number 10,654,921, [...]

Published
2020

247. Patent Application Titled 'Nanoscale Drug Carrier Capable Of Passing Through Blood-Brain Barrier' Published Online (USPTO 20200138960)

Subjects
Drug delivery systems -- Intellectual property, Amino acids -- Intellectual property, Carboplatin -- Intellectual property, Procyclidine -- Intellectual property, Biotechnology, Editors, Business, Health
Abstract

2020 MAY 29 (NewsRx) -- By a News Reporter-Staff News Editor at Medical Patent Business Week -- According to news reporting originating from Washington, D.C., by NewsRx journalists, a patent [...]

Published
2020

248. 'Treatment Of Non-Small Cell Lung Cancer' in Patent Application Approval Process (USPTO 20200129482)

Subjects
AbbVie Inc. -- Intellectual property, Rucaparib -- Intellectual property, Niraparib -- Intellectual property, Olaparib, Carboplatin -- Intellectual property, Non-small cell lung cancer, Small cell lung cancer, Anopheles, Antineoplastic agents, Biotechnology, Talazoparib, Editors, Lung cancer, Biotechnology industry, Pharmaceuticals and cosmetics industries
Abstract

2020 MAY 20 (NewsRx) -- By a News Reporter-Staff News Editor at Biotech Week -- A patent application by the inventors Ansell, Peter (Grayslake, IL); He, Lei (Northbrook, IL); Huang, [...]

Published
2020

249. Researchers Submit Patent Application, 'Nk-92 Cells And Il-15 Agonist Combination Therapy', for Approval (USPTO 20200121720)

Subjects
Vincristine -- Intellectual property, Skin cancer, Biochemistry, Carboplatin -- Intellectual property, Skin, Pembrolizumab, Anopheles, Cancer, Biotechnology, Editors, Biotechnology industry, Pharmaceuticals and cosmetics industries
Abstract

2020 MAY 13 (NewsRx) -- By a News Reporter-Staff News Editor at Biotech Week -- From Washington, D.C., NewsRx journalists report that a patent application by the inventors Klingemann, Hans [...]

Published
2020

250. Researchers Submit Patent Application, 'Triazole Bisphosphonate Geranylgeranyl Diphosphate Synthase Inhibitors', for Approval (USPTO 20200121701)

Subjects
Clinical trials, Vincristine -- Intellectual property, Carboplatin -- Intellectual property, Sulindac -- Intellectual property, Hydroxyprogesterone -- Intellectual property, Fluoxymesterone -- Intellectual property, Triazoles -- Intellectual property, Plant biochemistry, Editors, Health
Abstract

2020 MAY 11 (NewsRx) -- By a News Reporter-Staff News Editor at Clinical Trials Week -- From Washington, D.C., NewsRx journalists report that a patent application by the inventors Holstein, [...]

Published
2020

Catalog

Books, media, physical & digital resources
See catalog results